Rebuttals to "The Debate on Insulin vs. Non-insulin Use in the Hospital Setting-Continued Use of Insulin or Time to Revise the Guidelines?"
Smita Kumar, Mark E Molitch, Francisco J Pasquel, Maya Fayfman, Guillermo E Umpierrez
Author Information
- Smita Kumar: Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, 645 N. Michigan Ave., Suite 530, Chicago, IL, 60611, USA.
- Mark E Molitch: Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, 645 N. Michigan Ave., Suite 530, Chicago, IL, 60611, USA. molitch@northwestern.edu.
- Francisco J Pasquel: Emory University School of Medicine, 69 Jesse Hill Jr. Dr, Atlanta, GA, 30303, USA.
- Maya Fayfman: Emory University School of Medicine, 69 Jesse Hill Jr. Dr, Atlanta, GA, 30303, USA.
- Guillermo E Umpierrez: Emory University School of Medicine, 69 Jesse Hill Jr. Dr, Atlanta, GA, 30303, USA. geumpie@emory.edu.
No abstract text available.
Blood Glucose
Hospitals
Humans
Hypoglycemic Agents
Inpatients
Insulin
Blood Glucose
Hypoglycemic Agents
Insulin
